AC
MJN

Apertura Capital’s Mead Johnson Nutrition Company MJN Stock Holding History

Apertura Capital’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,000
Closed -$49.5M – 73
2016
Q4 		$49.5M Buy
+7,000
New +$522K 18.11% 1

Other funds holding MJN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Apertura Capital's MJN Position: Q4 2016 in Review

Apertura Capital sold out of Mead Johnson Nutrition Company (MJN) in Q4 2016, closing a stake of 100,000 shares — an estimated $7.45M sold.

Apertura Capital first reported a position in MJN in Q4 2015 and held it in 3 quarters. The position peaked at $7.9M in Q3 2016. 554 funds tracked by Wall St. Rank hold MJN as of Q4 2016.

  • Apertura Capital reported no remaining Mead Johnson Nutrition Company position as of Q4 2016 after selling out during the quarter.
  • Apertura Capital sold 100,000 Mead Johnson Nutrition Company shares in Q4 2016, an estimated $7.45M.
  • Apertura Capital first reported a position in Mead Johnson Nutrition Company in Q4 2015 and held it in 3 quarters.
  • Apertura Capital's Mead Johnson Nutrition Company position peaked at $7.9M in Q3 2016.
  • 554 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2016.

Based on Apertura Capital's 13F filing for Q4 2016, filed 10 Feb 2017.